Attacking the HIV-1 Entry Machine MECHANISM OF VIROLYSIS INDUCED BY PEPTIDE TRIAZOLE THIOLS.

Slides:



Advertisements
Similar presentations
HIV and its lifecycle Sources: Wikipedia, HIV is a retrovirus (enveloped viruses possessing an RNA genome,
Advertisements

Viruses Wkbk 20.1 Watch for vocab, diagrams, and understanding structure and function of viruses.
Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.
The gp41 fragment (purple) consists of a cytoplasmic tail and a hydrophobic membrane-spanning domain and is joined with the larger gp120 component (blue.
CCR5 : and HIV Immunity Gene Variation Works for and Against HIV Ashley Alexis & Hilda Hernandez.
Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs RL Stanfield, E Cabezas, AC Satterthwait, EA Stura, AT Profy,
THE REPLICATION OF VIRUSES Virology Lecture 2 Three lectures dealing with (1) replication of DNA viruses (2) the culture, growth and recognition of virus.
Lab of Immunoregulation
Two Examples of Docking Algorithms With thanks to Maria Teresa Gil Lucientes.
HIV Replication Rachel Carriger Biochemistry Fall 2004.
Antibodies Structure and Variability James Hebda 9/30/11.
VIRUS ENTRY.
_________________________________________________________________________.
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
TRANSLATIONAL RESEARCH New Therapies for MS Dennis Bourdette, M.D. and Arthur A. Vandenbark, Ph.D. TCR peptide therapy Recombinant TCR ligand (RTL) therapy.
HIV GP120 Envelope Protein
An Introduction to the HIV Problem Space Oakwood University: Faculty Quantitative Institute Aug. 10–12, 2009.
Antigen recognition by T cells Zheng W. Chen, M.D., Ph.D.
1 Mukund Modak, Ph. D. Dental Biochemistry 2013 Lecture 39.
Methods MHC class-I T cell epitope prediction for Nef Consensus and ancestral sequences of the Nef protein for the different HIV-1 subtypes were obtained.
Phagocyte. B cells Receptor B Cell Naïve B cell B cells and antibodies daughter cells produce antibodies phagocyte consumes an antibody coated virus.
Example: Critical Evaluation of a Paper Barthe et al. (2009) Dynamic and Structural Characterization of a Bacterial FHA Protein Reveals a New Autoinhibition.
Lab of Immunoregulation Berkower Lab Weiss Lab -- Angelo Spadaccini -- Russell Vassell -- Yisheng Ni -- Yong He -- Yisheng Ni -- Yong He –Hong Chen --
After a virus becomes active and replicates in a host cell, it destroys the host cell. Copies of the virus are then released into the host organism, where.
A Mutational Investigation of an HIV Patient’s GP120 Glycoprotein and it’s Implications on CD4 Binding Salita Kaistha Usrinus College, Collegeville PA.
Cyanovirin-N A sugar-binding antiviral protein Christian García Blanca Arroyo.
T-LYMPHOCYTE 1 Lecture 8 Dr. Zahoor. Objectives T-cell Function – Cells mediated immunity Type of T-cells 1. Cytotoxic T-cell – CD8 (Killer T-cell) 2.
CD4 and HIV Tan Swee Huang AIT UEEM by ED19.98 Bioengineering and Environmental Health.
Mutations on the V3 loop of gp120 may predict progression to AIDS Derese Getnet, Dr. Rebecca Roberts, Structural Biology, Ursinus College, Collegeville.
1 Molecular Mechanisms for gp160-Enhanced Apoptosis Keith J. Micoli, Olga A. Mamaeva, George Pan, Eric Hunter and Jay M. McDonald University of Alabama.
SPECIFIC IMMUNE SYSTEM. Specific body defenses: 1.It is antigen specific 2.It has “memory”
Residue Sequence and Structure in the Re evaluation the Categorization of HIV Progression in Subjects Based on CD4 T cell Decline Rates Angela Garibaldi.
Inhibition of enterovirus 71 entry by peptides targeting I β-sheet of VP1 protein Ming-Liang He, Ph.D The Chinese University of Hong Kong.
Vaccines: A Molecular View
Targeting Protein Phosphatase-1 for the Inhibition of HIV-1 Sergei Nekhai, Ph.D. NIGMS, NIH RCMI –NCRR NHLBI, NIH Civilian Research and Development Foundation.
Structure of V3-containing HIV-1 gp120 core Huang, C. C., Tang, M., Zhang, M. Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber,
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
Interferons Induction of synthesis Induction of antiviral activity Antiviral activities induced by interferons  and  Antiviral activities induced by.
HIV & Influenza Figure 2 | Schematic diagram of HIV‑1 and influenza A virus. Both HIV-1 and influenza A virus are approximately 80–120 nm in diameter and.
Molecular Modeling in Drug Discovery: an Overview
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Intracellular Pathogens Extracellular Pathogens
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
The V3 Region Expresses More Diversity in Amino Acid Sequence in AIDS Diagnosed Patients than in Non-Trending and AIDS Progressing Patients HIV Structure.
A Spring-loaded mechanism for the conformational change of Influenza Hemagglutinin Mani Foroohar.
Standard SB3d: Compare and contrast viruses with living organisms.
Bindings of oliver leaf extract (OLE) to HIV-1 fusion protein gp41 John Z.H. Zhang, Department of Chemistry, New York University Recent experimental study.
Volume 9, Issue 2, Pages (February 2002)
Structure of V3-containing HIV-1 gp120 core
LMU Department of Biology
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Kevin Paiz-Ramirez Janelle N. Ruiz.
Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing Fabs RL Stanfield, E Cabezas, AC Satterthwait, EA Stura, AT Profy,
The Rational Design of an AIDS Vaccine
Damjan S. Nikolic, Vincent Piguet  Journal of Investigative Dermatology 
Loyola Marymount University
Nicki Harmon, Samantha Hurndon, & Zeb Russo
A Model for How Ribosomal Release Factors Induce Peptidyl-tRNA Cleavage in Termination of Protein Synthesis  Stefan Trobro, Johan Åqvist  Molecular Cell 
Protein interactions during the flavivirus life cycle elucidated by MS-based proteomics. Protein interactions during the flavivirus life cycle elucidated.
Alexander Falkenhagen, Sadhna Joshi  Molecular Therapy - Nucleic Acids 
HIV-1 Entry Inhibitors in the Side Pocket
Michael S. Diamond, Theodore C. Pierson  Cell 
Volume 7, Issue 2, Pages (February 1999)
The Multiple Mechanisms of T Cell Receptor Cross-reactivity
Volume 123, Issue 7, Pages (December 2005)
Viruses TEK 4C: Compare structures of viruses to cells, describe viral reproduction, and describe the role of viruses in causing diseases such as HIV and.
Alignment of the deduced amino acid sequences of the myosin light chain 2 (MLC2) proteins. Alignment of the deduced amino acid sequences of the myosin.
Chloe Jones, Isabel Gonzaga, and Nicole Anguiano
PubMed Research Article
LC8 is structurally variable but conserved in sequence.
Selectivity-determining regions
Presentation transcript:

Attacking the HIV-1 Entry Machine MECHANISM OF VIROLYSIS INDUCED BY PEPTIDE TRIAZOLE THIOLS

HIV-1 Uses Dual Receptor Encounter and Metastability To Effect Cell Entry and Infection Can the Two Host Cell Receptors Be Suppressed Coordinately?

Origin of Peptide Triazole HIV-1 Env gp120 Inhibitors Ferrer & Harrison, JVI 1999Gopi et al., ChemMedChem 2006 KR13 Bastian et al., ChemMedChem 2010

Viral Inactivation by Peptide Triazoles (Residual Virion with antigenic gp41) Preventative vaccine Therapeutic vaccine (Inactivation before host cell encounter) Preventative microbicide Bastian et al., Retrovirology 2013

Peptide Triazole Binding in a Conserved Site of gp120 and the Conformational Entrapment Model of gp120 Antagonism Entrapment of gp120 in ‘Open’ Inactivated State By Peptide Triazole UnligandedActivated PT Emileh et al., Biochemistry 2013Tuzer et al., Proteins 2013

p24 Release Infers Virus Env Disruption What’s the mechanism? (non-Core CA p24 in virus: Briggs et al. Nature Struct Biol 2004)

Lysis Requires Free Thiol of KR13 KR13 KR13 Dimer

Mechanism of Lytic Inactivation KR13 vs KR13 Dimer

Peptide Triazole Thiols (PTT) Truncates

Functional Characterization of PTT Truncates

gp120 Protein Ligands Used to Deduce Likely Disulfides Targeted 2G D Cyanovirin

Effect of protein ligands on p24 release by PTTs

Molecular Docking Simulation C385-C418: Blue C378-C445: Yellow C296-C331: Purple C119-C205: Orange

Conclusions: -There is a discontinuous relationship between virolysis and peptide length, indicating that a minimal length is required for efficient virolysis. -The minimum linker length between PT pharmacophore and PT-SH appears needed to enable contact between SH and disulfides of the envelope protein. -V3 loop disulfide is implicated in the disulfide exchange process. -Our results support the hypothesis that thiol exchange occurs between the peptide C-terminal thiol group and a specific CD4 exposed disulfide cluster in gp120. -Key goals going forward are to refine the pharmacophore, identify the specific Env protein disulfides involved, investigate the disulfide exchange process of virolysis.

Thank you Chaiken Lab ◦Dr. Rachna Aneja ◦Dr. Arangassery Rosemary Bastian ◦Dr. Mark Contarino ◦Caitlin Duffy ◦Dr. Ali Emileh ◦Andrew Holmes, PhD Candidate ◦Dr. Kantharaju Kamanna ◦Dr. Huiyuan Li ◦Dr. Adel A. Rashad ◦Ramalingam Venkat Kalyana Sundaram, PhD Candidate ◦Dr. Ferit Tuzer